BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 35811617)

  • 1. Natural product-based radiopharmaceuticals: Focus on curcumin and its analogs, flavonoids, and marine peptides.
    Wongso H
    J Pharm Anal; 2022 Jun; 12(3):380-393. PubMed ID: 35811617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of Radiolabelled Curcumin and Its Derivatives in Medicinal Chemistry.
    Mari M; Carrozza D; Ferrari E; Asti M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases.
    Okarvi SM
    Med Res Rev; 2004 May; 24(3):357-97. PubMed ID: 14994368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeling strategies for tumor-targeting proteinaceous drugs.
    Sugiura G; Kühn H; Sauter M; Haberkorn U; Mier W
    Molecules; 2014 Feb; 19(2):2135-65. PubMed ID: 24552984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.
    Goins B; Bao A; Phillips WT
    Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The next generation of positron emission tomography radiopharmaceuticals in oncology.
    Rice SL; Roney CA; Daumar P; Lewis JS
    Semin Nucl Med; 2011 Jul; 41(4):265-82. PubMed ID: 21624561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents.
    Nurhidayah W; Setyawati LU; Daruwati I; Gazzali AM; Subroto T; Muchtaridi M
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosyntheses using fluorine-18: the art and science of late stage fluorination.
    Cole EL; Stewart MN; Littich R; Hoareau R; Scott PJ
    Curr Top Med Chem; 2014; 14(7):875-900. PubMed ID: 24484425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (99m)Tc and (111)In-labeling of small biomolecules: bifunctional chelators and related coordination chemistry.
    Chakraborty S; Liu S
    Curr Top Med Chem; 2010; 10(11):1113-34. PubMed ID: 20388113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiometal complexes: characterization and relevant in vitro studies.
    Jurisson S; Cutler C; Smith SV
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):222-34. PubMed ID: 18480740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (99m)Tc-radiolabelled peptides for tumour imaging: present and future.
    Bolzati C; Refosco F; Marchiani A; Ruzza P
    Curr Med Chem; 2010; 17(24):2656-83. PubMed ID: 20491630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
    Gali H; Hoffman TJ; Sieckman GL; Owen NK; Katti KV; Volkert WA
    Bioconjug Chem; 2001; 12(3):354-63. PubMed ID: 11353532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques for loading technetium-99m and rhenium-186/188 radionuclides into pre-formed liposomes for diagnostic imaging and radionuclide therapy.
    Goins B; Bao A; Phillips WT
    Methods Mol Biol; 2010; 606():469-91. PubMed ID: 20013416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated module radiolabeling of peptides and antibodies with gallium-68, lutetium-177 and iodine-131.
    De Decker M; Turner JH
    Cancer Biother Radiopharm; 2012 Feb; 27(1):72-6. PubMed ID: 22149590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase synthesis of peptide radiopharmaceuticals using Fmoc-N-epsilon-(hynic-Boc)-lysine, a technetium-binding amino acid: application to Tc-99m-labeled salmon calcitonin.
    Greenland WE; Howland K; Hardy J; Fogelman I; Blower PJ
    J Med Chem; 2003 Apr; 46(9):1751-7. PubMed ID: 12699393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyranone natural products as inspirations for catalytic reaction discovery and development.
    McDonald BR; Scheidt KA
    Acc Chem Res; 2015 Apr; 48(4):1172-83. PubMed ID: 25742935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.
    Okarvi SM
    Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Update on Extemporaneous Preparation of Radiopharmaceuticals Using Freeze-Dried Cold Kits.
    Mukherjee A
    Mini Rev Med Chem; 2021; 21(11):1322-1336. PubMed ID: 33319668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technetium-99m radiopharmaceuticals for in vivo diagnostics].
    Dokić DD
    Med Pregl; 2005; 58(3-4):180-4. PubMed ID: 16526218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma Emitters in Pancreatic Endocrine Tumors Imaging in the PET Era: Is there a Clinical Space for 99mTc-peptides?
    Briganti V; Cuccurullo V; Di Stasio GD; Mansi L
    Curr Radiopharm; 2019; 12(2):156-170. PubMed ID: 30827276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.